Psoriasis clinical trials at UC Irvine
2 in progress, 1 open to eligible people
Showing trials for
Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
open to eligible people ages 6-17
The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 17 years) with mild to moderate plaque psoriasis.
Orange, California and other locations
Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares
Sorry, in progress, not accepting new patients
This study is open to adults with a serious skin disease called generalized pustular psoriasis (GPP) who have repeated flares of GPP. The purpose of this study is to find out whether a medicine called spesolimab helps people with repeated flares of…
Irvine, California and other locations
Last updated: